CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-08-01 | NOEL MARK VP, Tech Management | Option exercise | +48,000 | $1.09 | $52K | 75,540 |
| 2012-08-01 | NOEL MARK VP, Tech Management | Sale | −48,000 | $4.74 | $228K | 27,540 |
| 2012-08-01 | NOEL MARK VP, Tech Management | Option exercise · Qualified stock option (right to buy) | +48,000 | $1.09 | $52K | 0 |
| 2012-06-19 | MCNAB JAMES R Director | Sale | −139,000 | $4.76 | $662K | 1,079,688 |
| 2012-06-18 | MCNAB JAMES R Director | Sale | −150,000 | $4.75 | $713K | 1,218,688 |
| 2012-06-15 | MCNAB JAMES R Director | Sale | −11,000 | $4.73 | $52K | 1,368,688 |
| 2012-05-01 | PASSERI DANIEL R CEO and Director | Option exercise | −36,000 | $1.09 | $39K | 161,750 |
| 2012-05-01 | PASSERI DANIEL R CEO and Director | Sale | −36,000 | $4.80 | $173K | 125,750 |
| 2012-05-01 | PASSERI DANIEL R CEO and Director | Option exercise · Non-qualified stock option | −36,000 | $1.09 | $39K | 0 |
| 2012-05-01 | NOEL MARK VP, Tech Management | Option exercise | +36,413 | $1.50 | $55K | 63,953 |
| 2012-05-01 | NOEL MARK VP, Tech Management | Sale | −36,413 | $4.78 | $174K | 27,540 |
| 2012-05-01 | NOEL MARK VP, Tech Management | Option exercise | +37,687 | $1.50 | $57K | 65,227 |
| 2012-05-01 | NOEL MARK VP, Tech Management | Sale | −37,687 | $4.78 | $180K | 27,540 |
| 2012-05-01 | NOEL MARK VP, Tech Management | Option exercise · Qualified stock option (right to buy) | +36,413 | $1.50 | $55K | 0 |
| 2012-05-01 | NOEL MARK VP, Tech Management | Option exercise · Non-qualified stock option (right to buy) | +37,687 | $1.50 | $57K | 0 |
| 2012-04-30 | PASSERI DANIEL R CEO and Director | Option exercise | +57,837 | $1.50 | $87K | 183,587 |
| 2012-04-30 | PASSERI DANIEL R CEO and Director | Sale | −57,837 | $4.83 | $279K | 125,750 |
| 2012-04-30 | PASSERI DANIEL R CEO and Director | Option exercise | +16,813 | $1.09 | $18K | 142,563 |
| 2012-04-30 | PASSERI DANIEL R CEO and Director | Sale | −16,813 | $4.83 | $81K | 125,750 |
| 2012-04-30 | PASSERI DANIEL R CEO and Director | Option exercise · Non-qualified stock option | −57,837 | $1.50 | $87K | 0 |
Page 18 of 29 · 564 trades